ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982